10 Best Nasdaq Stocks Under $5 to Buy
The Nasdaq is one of the top three most-followed stock market indices in the United States, comprising over 2,500 stocks.
Posts Tagged ‘NASDAQ:ABUS’
Jim Cramer’s Lightning Round: 7 Stocks Under the Spotlight
Jim Cramer, the host of Mad Money, offered his insights into the market's recent performance, highlighting why the tech-heavy Nasdaq failed to make a strong rebound.
Here’s Why Arbutus (ABUS) Surged in Q3
Tourlite Capital Management, an investment management firm, released its third quarter 2024 investor letter, a copy of which can be downloaded here.
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2024 Earnings Call Transcript
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2024 Earnings Call Transcript November 6, 2024Arbutus Biopharma Corporation reports earnings inline with expectations.
10 Best Debt-Free Penny Stocks to Buy Now
Inflation in the U.S. has dropped to the lowest level since 2021, setting the stage for the Federal Reserve to cut interest rates.
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma 2024 Second Quarter Financial Results and Corporate Update. [Operator Instructions].
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript
Arbutus Biopharma Corporation misses on earnings expectations. Reported EPS is $-0.10178 EPS, expectations were $-0.1.
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript
Arbutus Biopharma Corporation reports earnings inline with expectations. Reported EPS is $-0.12 EPS, expectations were $-0.12.
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Arbutus Third Quarter Corporate and Financial Update Conference Call.
12 Best Micro Cap Stocks To Invest In
In this piece, we will take a look at the 12 best micro cap stocks to invest in.
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Q2 Conference Call.
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma 2023 First Quarter Financial Results and Corporate Update Conference Call.
5 Best Debt Free Penny Stocks to Invest In
In this article, we will be taking a look at the 5 best debt free penny stocks to invest in.
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by.
5 Penny Stocks With Biggest Upside
In this article, we discuss the 5 penny stocks with the biggest upside.
5 Best High Volume Penny Stocks to Buy Now
In this article, we discuss the 5 best high volume penny stocks to buy now.
5 Penny Stocks to Buy in March
CTI BioPharma Corp. (NASDAQ:CTIC) is a biopharmaceutical company based in the United States, developing therapies for blood-related cancers.
5 Penny Stocks Most Popular on Reddit and Robinhood
In this article, we discuss the 5 penny stocks most popular on Reddit and Robinhood.
5 Penny Stocks to Buy in December
In this article, we discuss the 5 penny stocks to buy in December.
Hedge Fund and Insider Trading News: Maso Capital, Engine Capital, Cinctive Capital Management, Millennium Management, Third Point LLC, Elliott Advisors, Arbutus Biopharma Corp (ABUS), Opendoor Technologies Inc (OPEN), and More
Maso Capital, an event driven and convertible arbitrage-focused hedge fund based in Hong Kong, was established in 2012 by Manoj Jain and Sohit Khurana, who previously managed ...
5 Best Biotech Stocks Under $5
In this article, we will discuss the 5 best biotech stocks under $5 in 2021.
5 Penny Stocks With Long-Term Growth Catalysts
In this article, we discuss the 5 penny stocks with long-term growth catalysts.
Is ABUS A Good Stock To Buy Now?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Is Arbutus Biopharma Corp (ABUS) A Good Stock To Buy?
In this article we will take a look at whether hedge funds think Arbutus Biopharma Corp (NASDAQ:ABUS) is a good investment right now.
Arbutus Biopharma Corp (ABUS): Hedge Funds In Wait-and-See Mode
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.
Here’s What Hedge Funds Think About Arbutus Biopharma Corp (ABUS)
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Do Hedge Funds Love Arbutus Biopharma Corp (ABUS)?
"Value has performed relatively poorly since the 2017 shift, but we believe challenges to the S&P 500’s dominance are mounting and resulting active opportunities away from the...
13D Filing: QVT Financial and Arbutus Biopharma Corp (ABUS)
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-l(e), 240....
13D Filing: Viking Global and Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (NASDAQ:ABUS): Andreas Halvorsen's Viking Global filed an amended 13D.
You can check out Viking Global's latest holdings and filings here.
QVT Financial’s Investments, Performance, Letters
Daniel Gold, who holds a Bachelor of Arts degree in Physics from Harvard College, founded QVT Financial in 2004 after having worked for several years as a star trader at Deutsche...
13D Filing: Viking Global and Arbutus Biopharma Corp (ABUS)
You can access the original SEC filing by clicking here.
13D Filing: Viking Global and Arbutus Biopharma Corp (ABUS)
You can access the original SEC filing by clicking here.
Is Arbutus Biopharma Corp (ABUS) Worthy of Your Portfolio?
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money...
Arbutus Biopharma Corp (ABUS): Are Hedge Funds Right About This Stock?
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that...
